Biofidelity Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $24.3M

  • Investors
  • 10

Biofidelity General Information

Description

Developer of a novel molecular assay designed to broaden access to precision testing for all patients. The company's technology can detect a single molecule of mutated DNA against the background of a large number of healthy molecules present in a typical patient sample and can be implemented on existing laboratory instrumentation with a simple workflow and sensitivity, enabling oncologists to target the right treatments at the right time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 330 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0WN
  • England, United Kingdom
+44 01223
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 330 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0WN
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biofidelity Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 13-Apr-2024 $24.3M Completed Generating Revenue
5. Early Stage VC (Series A1) 01-Feb-2022 Completed Generating Revenue
4. Early Stage VC (Series A) 20-Aug-2020 Completed Generating Revenue
3. Grant 10-Oct-2019 Completed Generating Revenue
2. Seed Round 16-May-2019 $974K $974K Completed Generating Revenue
1. University Spin-Out 01-Feb-2019 Completed Generating Revenue
To view Biofidelity’s complete valuation and funding history, request access »

Biofidelity Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4
Series A-3
Series A-2
B Ordinary
Series A-2 2,019,769 $0.000013 $5.54 $5.54 2x $5.54 20.24%
Ordinary 477,707 $0.000013 $1.98 $1.98 1x $1.98 4.79%
To view Biofidelity’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biofidelity Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel molecular assay designed to broaden access to precision testing for all patients. The company's tec
Discovery Tools (Healthcare)
Cambridge, United Kingdom
25 As of 2025

San Diego, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biofidelity Competitors (4)

One of Biofidelity’s 4 competitors is Biocept, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocept Formerly VC-backed San Diego, CA
Foundation Medicine Formerly VC-backed Boston, MA
Qiagen Formerly VC-backed Hilden, Germany
Guardant Health Formerly VC-backed Palo Alto, CA
To view Biofidelity’s complete competitors history, request access »

Biofidelity Patents

Biofidelity Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4605551-A2 Nucleic acid analysis Pending 19-Oct-2022
US-20260110021-A1 Nucleic acid analysis Pending 19-Oct-2022
WO-2024084439-A2 Nucleic acid analysis Inactive 19-Oct-2022
WO-2024084439-A3 Nucleic acid analysis Inactive 19-Oct-2022
EP-4605546-A1 Nucleic acid enrichment and detection Pending 19-Oct-2022 C12Q1/6806
To view Biofidelity’s complete patent history, request access »

Biofidelity Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biofidelity Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Octopus Ventures Venture Capital Minority
Perscitus Family Office Minority
SBI Investment Venture Capital Minority
Agilent Technologies Corporation Minority
BlueYard Capital Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Biofidelity FAQs

  • When was Biofidelity founded?

    Biofidelity was founded in 2019.

  • Where is Biofidelity headquartered?

    Biofidelity is headquartered in Cambridge, United Kingdom.

  • What is the size of Biofidelity?

    Biofidelity has 25 total employees.

  • What industry is Biofidelity in?

    Biofidelity’s primary industry is Discovery Tools (Healthcare).

  • Is Biofidelity a private or public company?

    Biofidelity is a Private company.

  • What is the current valuation of Biofidelity?

    The current valuation of Biofidelity is .

  • What is Biofidelity’s current revenue?

    The current revenue for Biofidelity is .

  • How much funding has Biofidelity raised over time?

    Biofidelity has raised $61.4M.

  • Who are Biofidelity’s investors?

    Octopus Ventures, Perscitus, SBI Investment, Agilent Technologies, and BlueYard Capital are 5 of 10 investors who have invested in Biofidelity.

  • Who are Biofidelity’s competitors?

    Biocept, Foundation Medicine, Qiagen, and Guardant Health are competitors of Biofidelity.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process